US Patent Issued to REGENERON PHARMACEUTICALS on Nov. 4 for "Compositions and methods for using bispecific antibodies to bind complement and a target antigen" (New York, New Jersey Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,991, issued on Nov. 4, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Compositions and methods for using bispecific antibodies to bind complement and a target antigen" was invented by Christos Kyratsous (Irvington, N.Y.), Chia-Yang Lin (Scarsdale, N.Y.), Andrew J. Murphy (Croton-on-Hudson, N.Y.), Brinda Prasad (Princeton, N.J.) and Neil Stahl (Carmel, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "According to certain embodiments, the present disclosure provides bispecific antigen-binding molecules comprising a first antigen-binding domain that specifically binds a target antigen and a second antigen binding domain that binds...